Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2279-2280

  Babu, Tara ^a   Rekasius, Violeta ^a   Parada, Jorge P ^a,b   Schreckenberger, Paul ^a   Challapalli, Malliswari ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUPIROCIN; NASAL MUCOSA; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 67650086640     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01834-08     Document Type: Article

References (21)

1. Annigeri, R., J. Conly, S. Vas, et al. 2001. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21:554-559.
2. Capobianco, J. O., C. C. Doran, and R. C. Goldman. 1989. Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob. Agents Chemother. 33:156-163.
3. Casewell, M. W., and R. L. R. Hill. 1987. Mupirocin ("pesudomonic acid") - a promising new topical antimicrobial agent. J. Antimicrob. Chemother 19:1-5.
4. Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 41:11-18.
5. Fridkin, S. K., H. A. Hill, N. V. Volkova, et al. 2002. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg. Infect. Dis. 8:697-701.
6. Fuchs, P. C., R. N. Jones, and A. L. Barry. 1990. Interpretive criteria for disk-diffusion susceptibility testing of mupirocin, a topical antibiotic. J. Clin. Microbiol. 28:608-609.
7. Gilbart, J., C. R. Perry, and B. Slocombe. 1993. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob. Agents Chemother. 37:32-38.
8. Huang, S. S., and R. Platt. 2003. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin. Infect. Dis. 36:281-285.
9. Illinois General Assembly. 2007. Public act 095-0312. Legislative Information System, Springfield, IL. http://www.ilga.gov/legislation/publicacts/ fulltext.asp?Name=095-0312.
10. Jones, J. C., T. J. Rogers, P. Brookmeyer, et al. 2007. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin. Infect. Dis. 45:541-547.
11. Klevens, R. M., J. R. Edwards, F. C. Tenover, et al. 2006. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin. Infect. Dis. 42:389-391.
12. Kluytmans, J. A., J. W. Mouton, M. F. VandenBergh, et al. 1996. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 17:780-785.
13. Miller, M. A., A. Dascal, J. Portnoy, and J. Mendelson. 1996. Development of mupirocin resistance among methicillin resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect. Control Hosp. Epidemiol. 17:811-813.
14. Orrett, F. A. 2008. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Jpn. J. Infect. Dis. 61:107-110.
15. Pérez-Roth, E., C. López-Aguilar, J. Alcoba-Florez, and S. Méndez-Álvarez. 2006. High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages. Antimicrob. Agents Chemother. 50:3207-3211.
16. Peterson, L. R., J. L. Beaumont, and A. Robicsek. 2008. Benefits and drawbacks of universal surveillance of methicillin resistant Staphylococcus aureus. Ann. Intern. Med. 149:68-69.
17. Robicsek, A., J. L. Beaumont, S. M. Paule, et al. 2008. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann. Intern. Med. 148:409-418.
18. Santos, K. R., L. M. Teixeira, G. P. Bravo Neto, L. S. Fonseca, and P. P. Gontijo Filho. 1998. Mupirocin- and methicillin-resistant Staphylococcus aureus spreading in an intermediate-care unit in a Brazilian hospital. Infect. Control Hosp. Epidemiol. 19:622-623.
19. Semret, M., and M. A. Miller. 2001. Topical mupirocin for eradication of MRSA colonization with mupriocin-resistant strains. Infect. Control Hosp. Epidemiol. 22:578-580.
20. Upton, A., S. Lang, and H. Heffernan. 2003. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J. Antimicrob. Chemother. 51:613-617.
21. Yoo, J. I., E. S. Shin, J. O. Cha, et al. 2006. Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea. Antimicrob. Agents Chemother. 50:365-367.